Evaluation of the Efficacy and Safety of Short Time Bed Rest to Stop Bleeding with Exoseal Study

Evaluation of the Efficacy and Safety of Short Time Bed Rest to Stop Bleeding with Exoseal Study - E-stone Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012176

Enrollment

400

Registered

2013-10-30

Start date

2013-10-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral artery disease, Coronary artery disease

Interventions

Bed rest time is 2.5 hours after using Exoseal. Bed rest time is 4.0 hours after using Exoseal.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patiens for whom Exoseal is used to get hemostasis.

Exclusion criteria

Exclusion criteria: Patients who did not agree with this study

Design outcomes

Primary

Measure	Time frame
Pain score (efficacy outcome) Major adverse event within 30 days (safety outcome)	—

Countries

Japan

Contacts

Public ContactTakayuki Ishihara

Kansai Rosai Hospital Cardiovascular Center

t.ishihara31@gmail.com06-6416-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026